العربية
About Us
News
Fellowships
العربية
Home
About Us
CTGA Database
CTGA Overview
Search Database
Submit to Database
Publications
Research Articles
Genetics Made Easy
Genetic Disorders in the Arab World
Reports
Conferences & Events
News
Gallery
Fellowships
Contact Us
CYP2D6*103
Home
CYP2D6*103
HGVS Expressions
NG_008376.4:g.5990C>T(;)6769A>G(;)7870C>T(;)9200G>C
NM_000106.6:c.269C>T(;)496A>G(;)886C>T(;)1457G>C
NC_000022.11:g.42126611C>G(;)42127941G>A(;)42129042T>C(;)42129821G>A
Associated Genes
Cytochrome P450, Subfamily IID, Polypeptide 6
Back to search Result
CTGA Clinical Significance
Drug Response
Variant Type
Allele
dbSNP
267608309
1135824
16947
1135840
Epidemiology in the Arab World
View Map
United Arab Emirates
Subject ID
Country of Origin
Allele Count
Allele Frequency
CTGA Clinical Significance
Condition(s)
Reference
Remarks
608902.G.1.1
United Arab Emirates
Drug Response
Drug Metabolism, Poor, CYP2D6-Related
Qumsieh et al. 2011
151 UAE nationals
Download Table
Contributors
Pratibha Nair: 08.09.2021
Edit History
Sami Bizzari: 24.08.2022
Pratibha Nair: 08.09.2021
Back to search Result
×
Algeria
Bahrain
Comoros
Country not specified
Djibouti
Egypt
Eritrea
Iraq
Jordan
Kuwait
Lebanon
Libya
Mauritania
Morocco
Oman
Palestine
Qatar
Saudi Arabia
Somalia
Sudan
Syria
Tunisia
United Arab Emirates
Yemen
Arab Countries with reported incidence
Arab Countries without reported incidence
Non-Arab Countries
© CAGS 2024. All rights reserved.